INTRODUCTION {#sec1}
============

Cyprinid herpesvirus 3 (CyHV-3; species Cyprinid herpesvirus 3, genus Cyprinivirus, family Alloherpesviridae, order Herpesvirales), also known as koi herpesvirus (KHV), is the etiological agent of a lethal disease in common and koi carp. The common carp (Cyprinus carpio) is one of the main fish grown for human consumption ([@B1]). Moreover, its colorful ornamental varieties (koi carp) represent one of the most lucrative markets for individual freshwater fish ([@B2], [@B3]). As a result, CyHV-3 is considered to be the archetypal fish herpesvirus and is the subject of a growing number of studies ([@B4]).

The CyHV-3 genome is 295 kbp in size and thus the largest described among all herpesviruses ([@B5]). It encodes 155 potential protein-coding open reading frames (ORFs), a large number of which lack similarity to other herpesvirus genes ([@B5][@B6][@B7]). Nonetheless, CyHV-3 virions present the characteristic herpesvirus morphology ([@B8]), consisting of an icosahedral capsid containing the genome surrounded by an amorphous layer of proteins termed the tegument and enveloped in a lipid membrane bearing virion transmembrane proteins (VTPs) ([@B8]).

The protein composition of CyHV-3 virions has been investigated by mass spectrometry-based proteomic approaches for one European and two Chinese strains ([@B9], [@B10]). These analyses led to the identification of 46 virion proteins, of which 34 were detected in all three strains. Among these 34 proteins, 13 were classified as VTPs ([@B9], [@B10]). Since none of these proteins are related to viral proteins with known roles, it is not possible to predict their functions.

VTPs mediate key functions in the herpesvirus infectious cycle, such as binding virions to the cell and mediating entry, providing immune evasion mechanisms, facilitating virion morphogenesis, and promoting virion egress from the host cell. The expression of VTPs on the virion surface may also make them targets for neutralizing antibodies. As a result, it is important to study VTPs in order to understand the biology of infection and to aid in the design of candidate vaccines (attenuated, nonreplicative, or subunit). However, current knowledge of CyHV-3 VTPs is very limited. For example, it is not known whether any of the VTPs identified to date are required for viral replication *in vitro*.

Here, we performed proteomic and functional analyses of CyHV-3 VTPs. The proteome of CyHV-3 virions was revisited. Based on this new information and that published previously ([@B9], [@B10]), 16 VTPs were identified and selected for further study. Using recombination technologies, VTPs that are essential to viral growth *in vitro* were identified. Furthermore, the effects of deleting nonessential VTPs on viral growth *in vitro* and virulence *in vivo* were investigated. The knowledge gained represents a major breakthrough in understanding the biology of CyHV-3 and provides a firm basis for further research on alloherpesvirus VTPs.

RESULTS AND DISCUSSION {#sec2}
======================

Viral protein composition of CyHV-3 virions. {#sec2-1}
--------------------------------------------

We took advantage of the experience gained during our previous studies of the virion proteomes of herpesviruses ([@B9], [@B11][@B12][@B13]) to revisit the protein composition of extracellular CyHV-3 virions reported by us and others ([@B9], [@B10]). We selected a strategy based on SDS-PAGE separation of proteins, followed by liquid chromatography-tandem mass spectrometry (LC-MS/MS) of tryptic peptides, because this approach has been shown to enhance the recovery of peptides derived from proteins that are prone to aggregation or contain hydrophobic domains ([@B9], [@B11][@B12][@B13]). The data listed in [Table 1](#T1){ref-type="table"} represent independent analyses of three independent preparations of CyHV-3 virions. A total of 43 viral proteins were identified (based on detection in at least two of the preparations; [Table 1](#T1){ref-type="table"} and [Fig. 1](#F1){ref-type="fig"}). This number is identical to that determined by Yi et al. ([@B10]). Comparison of the proteomes derived from both studies revealed 39 proteins in common, with four proteins in each study that were not identified in the other ([Fig. 1](#F1){ref-type="fig"}).

###### 

Proteins identified by 2D LC-MS/MS in purified CyHV-3 virions[^*a*^](#T1F1){ref-type="table-fn"}

![](zjv02117-3009-t01)

![](zjv02117-3009-t01a)

Data are restricted to CyHV-3 proteins detected by SDS-PAGE and LC-MS/MS in at least two of the three independent preparations of purified virions. Predicted transmembrane proteins are shaded in gray. Protein features were based on previous publications ([@B6], [@B9]) or predictions made using TMHMM, SignalP, NetNGlyc 1.0, and the NetOGlyc 3.1 server from the CBS web site. Similarity and domain analyses were performed by BLASTP N-glyco and O-glyco, number of N glycosylations and O glycosylations, respectively.

^*b*^ No transmembrane domain was detected by software prediction. This sample was classified as a putative type 1 transmembrane protein on the basis of significant similarity to previously studied viral membrane proteins.

![CyHV-3 virion proteome. Schematic representation of CyHV-3 virion-associated proteins identified in independent studies: upper circle, analyses of the European FL strain performed in the present study; lower left circle, analyses of the FL strain performed in a former study ([@B9]); and lower right circle, analyses of two Chinese strains (GZ10 and GZ11) ([@B10]). Numbers represent CyHV-3 ORFs. Asterisks indicate viral proteins that were detected in only one of the two Chinese isolates. Predicted transmembrane proteins are underlined.](zjv9991830090001){#F1}

Yi et al. ([@B10]) identified ORF11, ORF27, ORF91, and ORF116 as potential virion proteins, whereas we did not. The lack of detection of ORF27 in our study was anticipated because this coding region is disrupted in the FL strain, as has been reported for other CyHV-3 strains ([@B5]). ORF91 and ORF116 were not detected in any of the preparations in the present study, and were identified by Yi et al. ([@B10]) for only one of the two Chinese strains, with detection being based on a single peptide that was supported by a low Mascot score ([@B10]). Similarly, ORF11 was detected on the basis of only one or two peptides (depending on the isolate) with relatively low Mascot scores. Among the four proteins that were detected in the present study and not by Yi et al. ([@B10]), two were detected in all three replicates (ORF4 and ORF64), and the two other were detected in only two replicates (ORF119 and ORF125). Finally, three proteins identified in our previous study were detected neither by Yi et al. ([@B10]) nor in the present study. Taking into account that these proteins were detected initially at relatively low abundances ([@B9]), it is likely that they represented contamination by nonstructural proteins.

In the context of the published bioinformatic analyses of the CyHV-3 genome ([@B5], [@B6]), the results presented above suggest that the FL strain of CyHV-3 encodes 16 predicted VTPs: ORF25, ORF32, ORF59, ORF64, ORF65, ORF81, ORF83, ORF99, ORF106, ORF108, ORF115, ORF131, ORF132, ORF136, ORF148, and ORF149.

CyHV-3 VTPs essential to viral growth *in vitro*. {#sec2-2}
-------------------------------------------------

The roles of CyHV-3 VTPs in viral replication *in vitro* were investigated by using bacterial artificial chromosome (BAC) cloning and prokaryotic recombination technologies to generate viral mutants ([Fig. 2](#F2){ref-type="fig"}). To facilitate the reconstitution of infectious viruses from recombinant plasmids, the BAC cassette was left in the viral genome leading to viruses expressing a truncated form of thymidine kinase (TK; encoded by ORF55) and enhanced green fluorescent protein (EGFP) (the BAC cassette is inserted at the 3′ end of ORF55 and encodes an EGFP expression cassette). The effect of TK truncation on viral replication *in vitro* and virulence *in vivo* has been documented previously. TK truncation was shown to have no effect on viral growth *in vitro* and to reduce virulence slightly *in vivo* ([@B14]). For each ORF predicted to encode a VTP, a single-gene-deletion recombinant plasmid was produced by replacing the ORF by a *galK* expression cassette. The molecular structures of all recombinant BAC plasmids produced were confirmed by a combined SacI digestion and Southern blotting approach and by sequencing the regions used to target recombination (data not shown). We then investigated the ability of the recombinant plasmids to reconstitute infectious virus after transfection into permissive CCB cells ([Fig. 3](#F3){ref-type="fig"}). Transfection was monitored by detecting EGFP-expressing cells (since the BAC cassette encodes an EGFP reporter gene) at 2 days postinfection (dpi). Examination of cell cultures at 4 dpi revealed the formation of viral plaques for the FL BAC plasmid (used as a positive control) and the BAC plasmids with ORF25, ORF64, ORF65, ORF108, ORF132, ORF136, ORF148, or ORF149 deleted, thereby demonstrating that these ORFs are nonessential for viral growth *in vitro*. Reconstituted viruses (i.e., viruses mutated in nonessential genes) were amplified, and their genomes were validated by full-length genome sequencing (data not shown) prior to further investigations (see below).

![Production of CyHV-3 recombinants to identify essential and nonessential VTPs. Deleted recombinant plasmids were produced for each ORF predicted to encode a VTP (FL BAC ORFX Del *galK* plasmids, with "X" standing for the number of the ORFs tested; these included ORF25, ORF32, ORF59, ORF64, ORF65, ORF81, ORF83, ORF99, ORF106, ORF108, ORF115, ORF131, ORF132, ORF136, ORF148, and ORF149). The effect of the deletion on the ability of the BAC plasmid to reconstitute infectious virus was tested by transfection into permissive CCB cells. Subsequently, for each gene identified as essential, two additional recombinant plasmids were produced to revert to wild-type ORFX sequence (FL BAC ORFX Rev1) or to insert a nonsense mutation (FL BAC ORFX NS). Plasmids were transfected into CCB cells to determine their ability to induce reconstitution of infectious virus. As an additional revertant control, FL BAC ORFX NS plasmids were cotransfected into CCB cells together with a fragment encoding the WT sequence of ORFX and flanking regions, in order to facilitate reversion to wild-type ORFX sequence by recombination in eukaryotic cells (FL BAC ORFX Rev2). To simplify the reading of the manuscript, some recombinants were given a short name (in red). The right part of the Fig. summarizes the genotype of the strains for ORF55 (TK) and ORFX. Del, deleted; WT, wild type; BAC, presence of the BAC cassette in the 3′ end of ORF55.](zjv9991830090002){#F2}

![Effect of deleting genes encoding VTPs on the ability of CyHV-3 FL BAC recombinant plasmids to reconstitute infectious virus. CCB cells were transfected with the plasmids indicated. At 2 and 4 dpi, the cells were examined by epifluorescence microscopy (the BAC cassette encodes EGFP). Scale bar, 1 mm. Plasmids able or not able to reconstitute infectious virus are labeled in green or red, respectively.](zjv9991830090003){#F3}

Transfection of BAC plasmids with ORF32, ORF59, ORF81, ORF83, ORF99, ORF106, ORF115, or ORF131 deleted did not induce the formation of CyHV-3 plaques ([Fig. 3](#F3){ref-type="fig"}), suggesting that these ORFs encode VTPs essential for viral growth *in vitro*. To test this hypothesis further, additional recombinant BAC plasmids were produced ([Fig. 2](#F2){ref-type="fig"}). The molecular structures of all recombinant BAC plasmids described below were confirmed by a combined SacI digestion and Southern blotting approach and by sequencing the regions used to target recombination (data not shown). To exclude the possibility that the lack of infectivity of the deleted recombinant BAC plasmids resulted from unexpected mutations generated during BAC manipulation, plasmids encoding revertant wild-type (WT) VTP ORF were derived (FL BAC ORFX Rev1 plasmids, [Fig. 2](#F2){ref-type="fig"}) from the deleted BAC plasmids. Transfection of each of the revertant plasmids into CCB cells led to viral growth ([Fig. 4](#F4){ref-type="fig"}, second column). To exclude the possibility that the lack of infectivity observed for the deleted BAC plasmids resulted from a polar effect of the deletion on the expression of a nearby essential gene, a recombinant plasmid in which the ORF was disrupted by a nonsense (NS) mutation was derived for each putative essential VTP gene (FL BAC ORFX NS plasmids, [Fig. 2](#F2){ref-type="fig"}). Transfection of these plasmids into CCB cells did not induce plaque formation ([Fig. 4](#F4){ref-type="fig"}, third column). To exclude the possibility that the lack of infectivity of the NS recombinant BAC plasmids resulted from unexpected mutations generated during BAC manipulation at the stage of NS mutagenesis, the FL BAC ORFX NS plasmids were transfected into CCB cells, together with a WT DNA fragment containing the relevant ORF and flanking regions, in order to induce reversion to a WT sequence after homologous recombination in eukaryotic cells. All plasmids led to viral growth when cotransfected with WT DNA fragments ([Fig. 4](#F4){ref-type="fig"}, fourth column). In summary, the results demonstrated that ORF32, ORF59, ORF81, ORF83, ORF99, ORF106, ORF115, and ORF131 encode VTPs essential to viral growth *in vitro*.

![Testing plasmids recombinant for CyHV-3 ORFs predicted to encode essential VTPs. For ORFs identified as essential in [Fig. 3](#F3){ref-type="fig"}, additional recombinant plasmids (ORFX Rev1 and ORFX NS) were produced (see [Fig. 2](#F2){ref-type="fig"}, description in the rectangular frame) and tested for their ability to reconstitute infectious virus after transfection into CCB permissive cells. At 6 days posttransfection, the cells were examined by epifluorescence microscopy for detection of EGFP. Scale bar, 1.5 mm.](zjv9991830090004){#F4}

These experiments identified essential *versus* nonessential VTPs of the FL strain of CyHV-3, as summarized in [Table 2](#T2){ref-type="table"}. To test whether the findings extend across the species Cyprinid herpesvirus 3, the ORFs encoding VTPs were sequenced from nine CyHV-3 strains with different geographical origins and passage histories ([Table 2](#T2){ref-type="table"}). All of the ORFs encoding essential VTPs were intact and exhibited a limited number of polymorphisms. In contrast, various ORFs encoding nonessential VTPs were truncated by disruptive mutations (highlighted in red in [Table 2](#T2){ref-type="table"}), the precise pattern depending on the strain.

###### 

Polymorphisms observed among CyHV-3 strains in ORFs encoding VTPs

  Gene     Requirement in FL strain   Mutation[^*a*^](#T2F1){ref-type="table-fn"}
  -------- -------------------------- -------------------------------------------------------------------------------------------------------------------------------------------------------------------
  ORF32    Essential                  No mutation
  ORF59    Essential                  No mutation
  ORF81    Essential                  No mutation
  ORF83    Essential                  Several aa inserted in M3, T, and J
  ORF99    Essential                  Several aa changed in KHV-I, M3, T, and J
  ORF106   Essential                  No mutation
  ORF115   Essential                  One aa changed in T
  ORF131   Essential                  One aa changed in KHV-I, FL, Cavoy, and T
  ORF25    Nonessential               Several aa inserted in M3, T, J, and GZ11
  ORF27    Nonessential               **Frameshifted in U, KHV-I, T, and GZ11; large regions deleted in FL; stop codon insertion in the beginning of the ORF in Cavoy**; several aa changed in M3 and J
  ORF64    Nonessential               **Frameshifted** and several amino acids deleted or inserted **in M3, T, and J**
  ORF65    Nonessential               One aa deleted in KHV-I, FL, Cavoy, I, and E; one aa inserted and several aa deleted in M3, T, and J; one aa changed in GZ11
  ORF108   Nonessential               One aa inserted, one aa changed and **a stop codon inserted at the end of the ORF**, several aa lost **in M3, T, and J**
  ORF132   Nonessential               One aa changed in KHV-I
  ORF136   Nonessential               Several aa inserted and **a stop codon inserted in the middle of the ORF in M3, T, and J**
  ORF148   Nonessential               Several aa inserted in KHV-I, Cavoy, and GZ11; Several aa deleted in M3, T, and J
  ORF149   Nonessential               One aa changed in KHV-I, Cavoy, and E, 13 aa inserted in M3 and J

Boldfacing indicates mutations that create an in-frame stop codon or frameshift. aa, amino acid(s).

Effects of deleting genes encoding nonessential VTPs on CyHV-3 growth *in vitro*. {#sec2-3}
---------------------------------------------------------------------------------

Considerations of the CyHV-3 gene arrangement suggested that deletion of ORF25, ORF64, ORF65, ORF108, ORF132, ORF136, or ORF148 would be unlikely to affect the expression of neighboring genes. In contrast, deletion of ORF149 might affect the expression of ORF148, resulting in the phenotype of TK BAC Δ149^galK^ representing the absence of expression of both proteins. To test this hypothesis, TK BAC Δ148^galK^ and TK BAC Δ149^galK^ plaques were stained with monospecific polyclonal antibodies (pAbs) against ORF148 or ORF149. Staining of TK BAC Δ149^galK^ plaques with the anti-ORF148 antibodies demonstrated the expression of the ORF148 protein (data not shown), implying that TK BAC Δ149^galK^ is adequate for investigating the effects of deleting ORF149.

The effect of deleting genes encoding nonessential VTPs on viral growth *in vitro* was investigated by multistep growth assay ([Fig. 5A](#F5){ref-type="fig"}) and plaque size assay ([Fig. 5B](#F5){ref-type="fig"}). Deletion of ORF25, ORF132, ORF136, ORF148, or ORF149 impaired CyHV-3 replication in the multistep growth assays to various degrees (based on observation of a significant effect for at least two consecutive time points). The more pronounced effect was observed for deletion of ORF25, which was associated with a 10-fold reduction in viral titer. In contrast, deleting ORF64, ORF65, or ORF108 had no major effect on CyHV-3 growth. The plaque size assays ([Fig. 5B](#F5){ref-type="fig"}), based on the results collected at 8 dpi, revealed that deleting ORF25, ORF108, ORF132, or ORF149 resulted in reduced plaque size, whereas deleting ORF64 led to an increased plaque size. Deleting ORF65, ORF136, or ORF148 did not significantly affect plaque size.

![Effects of deleting nonessential VTPs on CyHV-3 growth *in vitro*. (A) Multistep growth curves. CCB cells were infected with the viruses indicated and the titer (PFU/ml) in the cell supernatant was determined at the indicated time points postinfection. Data presented are the means ± the standard errors of the mean (SEM) of triplicate measurements. Significant differences between the deleted viruses and the TK BAC virus were tested by using two-way ANOVA, taking genotype and time postinfection as variables. (B) Plaque size assay. CCB cells were infected with the viruses indicated, and plaque areas were measured over time. The data presented are means ± the SEM for the measurement of 25 randomly selected plaques. Two-way ANOVA was used to test the significance of the results, taking genotype, time postinfection, and interaction between genotype and time postinfection as variables (\*, *P* \< 0.05; \*\*, *P* \< 0.01; \*\*\*, *P* \< 0.001).](zjv9991830090005){#F5}

Effect of deleting genes encoding nonessential VTPs on CyHV-3 virulence *in vivo*. {#sec2-4}
----------------------------------------------------------------------------------

All recombinant viruses deleted for a nonessential ORF (TK BAC ΔX^galK^, where X is the number of the ORF) were tested in triplicate for their virulence in carp ([Fig. 6](#F6){ref-type="fig"}). Fish infected with the TK BAC virus (used as a positive control) exhibited all the clinical signs associated with CyHV-3 disease, including apathy, folding of the dorsal fin, hyperemia, increased mucus secretion, skin lesions, suffocation, erratic swimming, and loss of equilibrium. At 30 dpi, the mean survival rate of TK BAC-infected fish was 41%. Fish inoculated with TK BAC Δ64^galK^, TK BAC Δ65^galK^, TK BAC Δ108^galK^, TK BAC Δ132^galK^, TK BAC Δ136^galK^, or TK BAC Δ149^galK^ exhibited comparable effects, leading to similar survival rates at 30 dpi (ranging between 33 and 56%). Conversely, fish infected with TK BAC Δ148^galK^ exhibited mild disease and a higher survival rate (77%, *P* \< 0.001). Fish inoculated with TK BAC Δ25^galK^ expressed no symptoms, and all survived the infection.

![Effect of deleting genes encoding nonessential VTPs on CyHV-3 virulence. The virulence of the indicated recombinant viruses was tested in carp (triplicate groups each consisting of 15 subjects; average weight, 1.90 ± 0.68 g, and average age, 3 months old). On day 0, fish were infected for 2 h by immersion in water containing 800 PFU/ml or mock infected. Survival rate was measured over a period of 30 days. The nine upper panels show the survival curves observed for replicates. The lower panel shows the mean survival curves based on the three replicates.](zjv9991830090006){#F6}

To ensure that each group of fish was infected with the correct virus and to exclude any possibility of viruses spreading among the tanks, PCR assays were performed on three randomly selected dead fish from each infected group (for TK BAC Δ25^galK^-infected fish, three fish were selected randomly from the living fish at 30 dpi), one fish infected with the TK BAC virus, and one mock-infected fish selected randomly at the end of the experiment ([Fig. 7](#F7){ref-type="fig"}). PCR performed with the ORF112intfw/ORF112intrev primer pair confirmed that samples from all but one group contained the CyHV-3 genome (the exception being the TK BAC Δ25^galK^-infected group). PCR performed with primers specific for the deleted ORFs confirmed that each group had been infected with the correct virus and that cross-contamination among tanks had not occurred ([Fig. 7](#F7){ref-type="fig"}).

![PCR detection and characterization of CyHV-3 genomes recovered from infected dead carp. DNA was extracted from the gills of three dead carp from each of the groups infected with the recombinant viruses deleted for a nonessential gene (TK BAC ΔORFX^galK^) during the course of the experiment described in the legend of [Fig. 6](#F6){ref-type="fig"}. In the TK BAC Δ25^galK^ infections, no fish died, and hence three fish were selected randomly from among the living fish at 30 dpi. A carp infected with TK BAC virus and a mock-infected carp were used as positive and negative PCR controls, respectively. PCRs were performed with the appropriate ORFXintfw/ORFXintrev primer pair and with the ORF112intfw/ORF112intrev primer pair. The images are photographs of agarose gels. The numbers on the left of each panel are marker sizes (bp). NC, negative control.](zjv9991830090007){#F7}

Testing of an ORF25-deleted recombinant as an attenuated vaccine candidate against CyHV-3. {#sec2-5}
------------------------------------------------------------------------------------------

The attenuation described above for TK BAC Δ25^galK^, from which ORF25 was deleted and encoding a truncated form of TK, suggested that a virus deleted only for ORF25 would have potential as an attenuated recombinant vaccine against CyHV-3. The requisite recombinant (Δ25^galK^, with ORF25 deleted and encoding a wild-type TK) was produced by following the procedure described in [Fig. 8](#F8){ref-type="fig"} and in Materials and Methods. The failure to detect virus by PCR in the gills of fish infected with the TK BAC Δ25^galK^ virus ([Fig. 7](#F7){ref-type="fig"}) suggests that deletion of ORF25 could affect the ability of deleted virions to infect fish or to spread within their host. To test this hypothesis and to compare the tropism of a virus lacking ORF25 (Δ25^galK^) to the tropism of a previously described recombinant vaccine candidate (deleted for ORF56 and ORF57, Δ56-57), the following experiment was performed. Fish were infected with the FL BAC revertant virus (WT, wild-type for TK and for ORF25), FL BAC revertant ORF25 Del galK virus (Δ25^galK^, wild-type for TK but with ORF25 deleted), or the FL BAC revertant ORF56-57 Del virus (Δ56-57, wild-type for TK but with ORF56-57 deleted) ([Fig. 9](#F9){ref-type="fig"}). The viral charge was measured by qPCR over time in the skin (the portal of entry of CyHV-3) and the heart (selected as an internal organ). The results demonstrated that the ORF25 deleted virus infects fish through skin infection and then spreads to internal organs as reported previously for the WT parental virus and the Δ56-57 virus ([@B15]). However, compared to the parental WT virus, the replication of the ORF25 deleted virus was reduced in intensity and duration to levels similar to those observed for the Δ56-57 virus.

![Flow chart of the production of CyHV-3 recombinants deleted for ORF25 or ORF56-57. Recombinants were given a short name (in red) for use in the text. Viral genotypes for ORF55 (TK), ORF25, and ORF56-57 are given on the right. Del, deleted; WT, wild type.](zjv9991830090008){#F8}

![Effect of ORF25 deletion on viral tropism according to qPCR analysis. At time zero, carp (average weight, 6.10 g ± 1.39 g; average age, 6 months old) were infected for 2 h by immersion in water containing the virus indicated at 800 PFU/ml and then returned to larger tanks. At the indicated time points, fish were sampled and submitted to qPCR analysis. The data obtained for each fish (according to viral genotype and time postinfection) are represented by the same symbol to allow correlation of the data obtained for the two tested organs. The number of viral genome copies is expressed as the log~10~ per 10^6^ carp glucokinase gene copies. Individual values represent the mean of duplicate measurements. Mock-infected fish were used as a negative control and no viral genome copies were detected in these fish. The number of positive fish among six analyzed fish is represented by gray bars. Viral charges \[viral genome copies/10^6^ carp glucokinase gene copies (log~10~)\] were compared using one-way ANOVA taking the viral genotype as a variable.](zjv9991830090009){#F9}

Next, the virulence of the Δ25^galK^ virus was compared to that of the WT strain and the previously described Δ56-57 attenuated virus ([Fig. 10](#F10){ref-type="fig"}) ([@B15]). A high degree of attenuation of Δ25^galK^ was indicated by the finding that infected fish exhibited no mortality or symptoms ([Fig. 10](#F10){ref-type="fig"}). The level of immune protection conferred by primary infection with Δ25^galK^ or Δ56-57 virus was tested by challenging infected fish with the M3 or FL strains of CyHV-3 ([Fig. 10](#F10){ref-type="fig"}, middle and lower lines of the graph, respectively). The fish vaccinated with Δ25^galK^ exhibited a poor level of protection, independent of the dose used for primary infection and the challenge strain used, with the relative percentage survival at a maximum of 34 when the fish were vaccinated at a dose of 400 PFU/ml and challenged with the M3 strain. In comparison, vaccination with the Δ56-57 attenuated virus resulted in a relative percentage survival of 84 under the same conditions ([Fig. 10](#F10){ref-type="fig"}).

![Testing of Δ25^galK^ and Δ56-57 deletion recombinants as attenuated recombinant vaccine candidates. The virulence of the recombinant viruses indicated was first tested in carp (first line of graph: four replicates per condition; *n* = 20 fish; average weight, 2.42 ± 0.95 g; average age, 6 months old). On day 0, fish were mock infected or infected for 2 h by immersion in water containing 40 (dotted line) or 400 (continuous line) PFU of virus/ml. The survival rate was measured over a period of 42 days. The immune protection conferred by primary infection was then tested for Δ25^galK^ and Δ56-57-infected fish at 42 dpi by distributing mock-infected fish and fish that survived the primary infection into duplicate tanks (*n* = 20) and challenging them by cohabitation with fish infected with the M3 strain (middle line of graphs) or the FL strain of CyHV-3 (lower line of graphs). The survival rate was measured according to time postchallenge.](zjv9991830090010){#F10}

The data above demonstrated that the VTP encoded by ORF25 is nonessential for viral replication *in vitro* but acts as a key virulence factor *in vivo*. ORF25 is the prototypical gene of the ORF25 family, which contains six paralogs (ORF25, ORF26, ORF27, ORF65, ORF148, and ORF149) encoding type I transmembrane proteins ([@B5]). Although ORF26 is a pseudogene, all other paralogs encode CyHV-3 VTPs. The FL strain used in this study as the parental strain encodes a disrupted ORF27, as has been reported for other strains of CyHV-3 ([@B5]). Individual deletions of each member of the ORF25 family in this ORF27-negative background revealed that none of them is essential for viral replication *in vitro*, although it is possible that this is the consequence of redundant functions expressed by the paralogs. The attenuation observed for a mutant lacking ORF25 suggested that this locus might serve as a target for generating recombinant attenuated vaccines. However, there are two points of caution in relation to this hypothesis: the ORF25 deletion virus induced weak immune protection, and it is possible that reversion to virulence could occur by mutation of the paralogous genes.

Concluding remarks. {#sec2-6}
-------------------

Herpesvirus VTPs play crucial roles in the viral life cycle. Although the functions of VTPs in members of the family Herpesviridae have been studied extensively, very little information is available on VTPs in members of the family Alloherpesviridae. The very distant evolutionary origin of these families has resulted in a lack of detectable genetic similarity between VTPs in the two groups. This situation makes it impossible to advance hypotheses on the roles of alloherpesvirus VTPs on the basis of the much more extensive knowledge available for other herpesviruses. The present study of the archetypal fish alloherpesvirus has enabled major steps to be taken toward characterizing alloherpesvirus VTPs: (i) the number of CyHV-3 VTPs was expanded from 14 to 16; (ii) these were characterized as consisting of eight essential and nine nonessential proteins; (iii) individual deletion of seven nonessential VTPs affected viral growth *in vitro*, and individual deletion of two affected virulence *in vivo*; and (iv) a mutant lacking ORF25 proved to be highly attenuated *in vivo* but induced a poor immune protection against a lethal challenge. This study provides a firm basis for the further study of alloherpesvirus VTPs.

MATERIALS AND METHODS {#sec3}
=====================

Cells and viruses. {#sec3-1}
------------------

Cyprinus carpio brain (CCB) cells ([@B16]) were cultured as described previously ([@B14]). The CyHV-3 FL strain was isolated in Belgium from a fish that had died from CyHV-3 infection and had been used to produce the FL BAC plasmid ([@B14]). Other CyHV-3 strains from different geographical origins were also used: the M3 strain from Belgium, the U strain from the United States ([@B5]); the J strain from Japan ([@B5]), the E strain from England (kindly provided by K. Way), the T strain from Taiwan ([@B17]), the GZ11 strain from China ([@B18]), and the KHV-I and I strains from Israel ([@B5]). The attenuated Cavoy strain from Israel was produced by passaging in cell culture ([@B19]).

Production and purification of CyHV-3 virions. {#sec3-2}
----------------------------------------------

CCB cells were infected with the CyHV-3 FL strain at a multiplicity of infection (MOI) of 0.02 PFU/cell ([@B20]). The supernatant was harvested at the beginning of viral release, when cell lysis was minimal (4 dpi). Virions were purified from the cell supernatant and monitored for purity as described previously ([@B9]).

SDS-PAGE and LC-MS/MS proteomic analysis. {#sec3-3}
-----------------------------------------

Virion proteins were separated by SDS-PAGE and detected by Coomassie blue staining. The entire lanes of the gel were cut into 30 equally sized slices, which were subjected to in-gel trypsin digestion ([@B21]). Peptides were separated by reversed-phase chromatography using a 40-min CAN gradient (4 to 45%) and analyzed by using an HCT ultra-ion trap (Bruker) in data-dependent AutoMS ([@B2]) mode with a scan range of 100 to 2,800 *m/z* and three averages, and five precursor ions at 300 to 1,500 *m/z* were selected from the MS scan. Precursors were actively excluded within a 0.5 min window, and all singly charged ions were excluded. The MS data were processed by using Mascot distiller, and all single-slice analyses were merged into a single data set. The data were searched for matches to CyHV-3 protein sequences (160 entries) by using an in-house Mascot 2.2 server (Matrix Science). The default search parameters used were as follows: enzyme = trypsin, maximum missed cleavages = 1, fixed modifications = carbamidomethyl (C), variable modifications = oxidation (M), peptide tolerance ± 1.3 Da; MS/MS tolerance = ± 0.5 Da, and instrument = ESI-TRAP. Only sequences identified by a Mascot score of \>30 were considered, and single peptide identification was systematically evaluated manually. In addition, the emPAI ([@B22]) value was calculated to estimate relative protein abundance in the GC extract only.

Antibodies. {#sec3-4}
-----------

Mouse pAbs against CyHV-3 ORF148 or ORF149 were produced by customized DNA immunization (DelphiGenetics).

Cloning and site-directed mutagenesis of CyHV-3 ORFs. {#sec3-5}
-----------------------------------------------------

DNA fragments containing CyHV-3 ORFs of interest plus at least 200 bp upstream and downstream were amplified by PCR using CyHV-3 FL BAC DNA as a template (see [Table 3](#T3){ref-type="table"} for primer details). The amplification products were TA cloned into the pGEM-T-Easy vector (Promega), and the resulting clones (pGEM-T-ORFX WT, X standing for the number of the ORF tested) with the correct sequence were used as a recombination cassette or as a template for mutagenesis. For ORFs encoding VTPs, site-directed mutagenesis was used to create 1- or 2-bp substitutions changing a tyrosine or a tryptophan codon into a stop codon, resulting in pGEM-T-ORFX NS. Oligonucleotide primers were designed by using the QuikChange primer design tool (<http://www.genomics.agilent.com/primerDesignProgram.jsp>) ([Table 3](#T3){ref-type="table"}).

###### 

Oligonucleotide primers[^*a*^](#T3F1){ref-type="table-fn"}

  Analysis                                                 Primer                    Sequence (5′--3′)[^*b*^](#T3F2){ref-type="table-fn"}                                                           Coordinates or accession no.
  -------------------------------------------------------- ------------------------- -------------------------------------------------------------------------------------------------------------- -----------------------------------------------------------
  Synthesis of inserts                                                                                                                                                                              
      CyHV-3 ORF25                                         ORF25outF                 CCTCCGACTCTGAAGACGAT                                                                                           45389--45408
                                                           ORF25outR                 GGTACGTGATGCTGTAGAAG                                                                                           47569--47588
      CyHV-3 ORF32                                         ORF32outF                 CCAGGTCCAGGCAGTCTC                                                                                             54216--54233
                                                           ORF32outR                 ATGCGCGTCTACAAGATCG                                                                                            55619--55601
      CyHV-3 ORF59                                         ORF59outF                 GACGCCTGTCTCTGGTAGA                                                                                            101541--101559
                                                           ORF59outR                 GCGTCTCCAAAAAGAGCGG                                                                                            102941--102923
      CyHV-3 ORF64                                         ORF64outF                 GTCGAGATATCCGAGGCAGA                                                                                           119716--119735
                                                           ORF64outR                 TTCATAGCCACAACCGGAGT                                                                                           122203--122184
      CyHV-3 ORF65                                         ORF65outF                 TGGAGAACATCAAGCAGCAC                                                                                           121920--121939
                                                           ORF65outR                 GAAGTCTGAAACTGTCTGAATG                                                                                         124106--124127
      CyHV-3 ORF81                                         ORF81outF                 GGTTTAGTCCAAATCCGACCT                                                                                          150519--150539
                                                           ORF81outR                 GCAGCTTCTGCTTCAGAGTG                                                                                           152023--152004
      CyHV-3 ORF83                                         ORF83outF                 ACACGCTGATGGTCACGAG                                                                                            152549--152567
                                                           ORF83outR                 ACACCAACCAGTTCGTGCAG                                                                                           153638--153619
      CyHV-3 ORF99                                         ORF99intF                 GCTTAGCCTGTTCGGCAC                                                                                             184445--184462
                                                           ORF99intR                 AAGATCTGGGACACGGACTG                                                                                           185515--185496
      CyHV-3 ORF106                                        ORF106outF                GCTGACACCTGTCACAACCA                                                                                           195629--195648
                                                           ORF106outR                TCGTGAGGACAAACCGTCTC                                                                                           196189--196170
      CyHV-3 ORF108                                        ORF108outF                GATGATGAAGGGTGTTCATG                                                                                           201067--201086
                                                           ORF108outR                CATCTACAAGTCGGACAACC                                                                                           201937--201956
      CyHV-3 ORF115                                        ORF115outF                CACGTAAACGAAGCCCCATA                                                                                           207951--207970
                                                           ORF115outR                ATTCGTGGCGGCTGTTATAC                                                                                           210734--210715
      CyHV-3 ORF131                                        ORF131outF                GCCCTGGTCCTCGTACTTTT                                                                                           224971--224990
                                                           ORF131outR                CTGATCAGATTCTCAGGAGCAG                                                                                         227271--227250
      CyHV-3 ORF132                                        ORF132outF                GCTCCTGAGAATCTGATCAG                                                                                           227252--227271
                                                           ORF132outR                GTTAATGGTCACAGAAGCGC                                                                                           228155--228174
      CyHV-3 ORF136                                        ORF136outF                GTGTCAAGTACGTGGAGCGT                                                                                           231157--231176
                                                           ORF136outR                GGCCTCTGAATGTGTTATTGC                                                                                          231991--232011
      CyHV-3 ORF148                                        ORF148outF                CATGGTTCGAGGTTGTGAAG                                                                                           253808--253827
                                                           ORF148outR                CAGCATTCGTCTCTTAGTGC                                                                                           255933--255952
      CyHV-3 ORF149                                        ORF149outF                ACCCTATCATGATTGACGGC                                                                                           255770--255789
                                                           ORF149outR                CTTTCGTTCTACTGTTCCTC                                                                                           258172--258191
  Synthesis of *galK* recombination cassettes                                                                                                                                                       
      ORF 25 Del *galK*                                    ORF25 *galK* F            [GTCATTTTTCCTCGTGGTGTGCAGCTTTTTCTAACGTGTGGTAGGACGCTAACCATTACCAAGTAAACCATTACG]{.ul}*CCTGTTGACAATTAATCATCGGCA*   45495--45569
                                                           ORF25 *galK* R            [TGACCAGGGTAGAATGATAGACCCGCCGCTAAGAAAAATGACTCTCCGTCCGCTACCGTCGCCCGCTATAGTGTT]{.ul}*TCAGCACTGTCCTGCTCCTT*       47376--47450
      ORF 32 Del *galK*                                    ORF32 *galK* F            [ATAATACGCACCCTGGTCACTTTCTTTAACGTGTCCGTGTCGGGCTCCCTACACGTTTCCTCCGAGTCGCCGATC]{.ul}*CCTGTTGACAATTAATCATCGGCA*   54417--54491
                                                           ORF32 g*alK* R            [CTGTATCCCATCAGGGGCTGATCTGCTGACGGCCTCGACGTGGTGGTGATGGTGGTGGTGGTGGTGATGATGATG]{.ul}*TCAGCACTGTCCTGCTCCTT*       54491--54417
      ORF 59 Del *galK*                                    ORF59 *galK* F            [CCCGCACGACGTCGGACGCTCCCTACCGAGTGAGCCGTCTCTCTGACCCGGGTCGTGCGGGCGCCACCAGCCCTT]{.ul}*CCTGTTGACAATTAATCATCGGCA*   101961--102035
                                                           ORF59 *galK* R            [AGCAGTGGTAGTCCTCTCACCCCCCCCCCCCCCCCCTTGACCTTCACCCTTCACCCCTAACCCCAACAACCAACC]{.ul}*TCAGCACTGTCCTGCTCCTT*       102521--102447
      ORF 64 Del *galK*                                    ORF64 *galK* F            [TGGTCCTCCCATGCTTTTTATTCAATCCTGCTCCTCTTGAAAAGCTTAAG]{.ul}*CCTGTTGACAATTAATCATCGGCA*                            119814--119863
                                                           ORF64 *galK* R            [GTACACTATATTGCGTTTATTTGTTTTTCATAAAAAGCACATACATAATA]{.ul}*TCAGCACTGTCCTGCTCCTT*                                122082--122033
      ORF 65 Del *galK*                                    ORF65 *galK* F            [CAATATAGTGTACACCGTGGTCTTTATTAATTTGATAACATAATAATGTA]{.ul}*CCTGTTGACAATTAATCATCGGCA*                            122070--122119
                                                           ORF65 *galK* R            [CAAGACGCCTCACACGACGGAAACCCGCAACACCACCCCACAAACAAACG]{.ul}*TCAGCACTGTCCTGCTCCTT*                                123911--123960
      ORF 81 Del *galK*                                    ORF81 *galK* F            [GCACTTGAGAGCAGCGGAGGAGAAGACCGGTGCATCCATCTCGACGCTCGTCAGGTTGTGACTGTCCTCGTCCTC]{.ul}*CCTGTTGACAATTAATCATCGGCA*   150722--150796
                                                           ORF81 *galK* R            [CGGCTGCTGTGTTTTGTGGTGCTGGCCTCGACTGTGGGGTGGTGGTGGCGGCGACTGCGAGAGGCTTCGGAA]{.ul}*TCAGCACTGTCCTGCTCCTT*          150796--150722
      ORF 83 Del *galK*                                    ORF83 *galK* F            [CACAATAAAAAGCTCCCCTCGGGGATCACCAAGACAACCTTTCAGTAGCC]{.ul}*CCTGTTGACAATTAATCATCGGCA*                            153481--153530
                                                           ORF83 *galK* R            [TCTTCGCCCTCGCCCTCGTCCCTCAACCTGTTGTACCTATACGCGCTCAT]{.ul}*TCAGCACTGTCCTGCTCCTT*                                152758--152807
      ORF 99 Del *galK*                                    ORF99 *galK* F            [TGCAGGCCACCGCCGCCAACGCCGAGATGTCCAACAACCTCCAGACGCAG]{.ul}*CCTGTTGACAATTAATCATCGGCA*                            184714--184763
                                                           ORF99 *galK* R            [AGGGCTTGCTCTTGAGGAAGGGCTGGTTGACGGGGCAGCCCTGCAGGTAA]{.ul}*TCAGCACTGTCCTGCTCCTT*                                185214--185165
      ORF 106 Del *galK*                                   ORF106 *galK* F           [ACTACTCGCCCACCGCCTTATACAACTTCACCGCGTATCCGCCGTACATC]{.ul}*CCTGTTGACAATTAATCATCGGCA*                            195727--195776
                                                           ORF106 *galK* R           [GGGTTTGGTAGAGGGCGCTGCGGGGGATGAGCCCGACGATACCGCTGCGG]{.ul}*TCAGCACTGTCCTGCTCCTT*                                196063--196014
      ORF 108 Del *galK*                                   ORF108 *galK* F           [CACTTAGTCTACCACTCACTTTACCTTACAACCACCCAGACACCAACACACCACACCACCCACACTACGAGCGAG]{.ul}*CCTGTTGACAATTAATCATCGGCA*   201156--201230
                                                           ORF108 *galK* R           [ACCAAGCAACACGTTCATGTGATTTTTTTTTATTGTTGATGTTGTTTGATGTATTACAGTTACAATAAACGTAAT]{.ul}*TCAGCACTGTCCTGCTCCTT*       201819--201893
      ORF 115 Del *galK*                                   ORF115 *galK* F           [ATCGTGTCCTCCGTCTCGGTCATCTCTGTGGTTTTTTCCAGCTTTGCGCC]{.ul}*CCTGTTGACAATTAATCATCGGCA*                            208152--208226
                                                           ORF115 *galK* R           [GCTCAAAATAAAAAAAACATGTCTGGACCTTTACATCTTGTTTCAATAAT]{.ul}*TCAGCACTGTCCTGCTCCTT*                                210641--210567
      ORF 131 Del *galK*                                   ORF131 *galK* F           [GTGAGGGAGTGATATGGAGTGAACGTAAATGGAGGGGCGCTGCGGAGGTT]{.ul}*CCTGTTGACAATTAATCATCGGCA*                            225410--225484
                                                           ORf131 *galK* R           [TCGAGACGCCCGAACTGGTCGAGGCCTACGTGAACGACGTCAAGGTCCGC]{.ul}*TCAGCACTGTCCTGCTCCTT*                                226426--226352
      ORF 132 Del *galK*                                   ORF132 *galK* F           [TCAAGTCTTTATTATTACTTTATTTAATGGGGTTCGGTTGGAGAAGAGCAGTCAAGTGAGCAGAAGAGAAGATCG]{.ul}*CCTGTTGACAATTAATCATCGGCA*   227369--227443
                                                           ORF132 *galK* R           [AACTGAGGCCTCTCCGGCTATCCGCACCGAGTGATATACCGCCCGCCACTACCCCAGAACCCCCACACAGCCGCA]{.ul}*TCAGCACTGTCCTGCTCCTT*       227957--228031
      ORF 136 Del *galK*                                   ORF136 *galK* F           [AAGCTTGCCTTTGAAACATGGAAAAGAGCTCTCGTGTGTTTCTTTAGAATAAGACGACGTCGAGCGACGACCATC]{.ul}*CCTGTTGACAATTAATCATCGGCA*   231264--231337
                                                           ORF136 *galK* R           [TGTTGGTTTGCTTTGGCTTGATAGCACACAAAAATCACATTTGTAAGAGTTTTATTGTTTGACAATGATACATCA]{.ul}*TCAGCACTGTCCTGCTCCTT*       231801--231875
      ORF 148 Del *galK*                                   ORF148 *galK* F           [GAGGGTAGAGAGGGCTGGAGAGTAGGAGAGGAGAGAGGGGAAAGTTTTGAAGTTCTTGCACATGTTGAGGGGAAG]{.ul}*CCTGTTGACAATTAATCATCGGCA*   253881--253955
                                                           ORF148 *galK* R           [AAAACCAAAATTTTTCTGTTATCGTATCGTGATGAGCGCGACCGAGGCGACGGTCCAGTAACTCCGCCGTCAATC]{.ul}*TCAGCACTGTCCTGCTCCTT*       255780--255854
      ORF 149 Del *galK*                                   ORF149 *galK* F           [TTTGCTTTTTTTATTATGTGATGCTGTAGTGTACACACGTATTAGAAACAATAGTAGAGCAAGCAAGCAAAAGC]{.ul}*CCTGTTGACAATTAATCATCGGCA*    255861--255935
                                                           ORF149 *galK* R           [TTTTCTTTTGACGCGCAATGACCGACGGCTCAAGTGACGGCTACCTAGACGATACGTCACAGACGGCTGAGGACC]{.ul}*TCAGCACTGTCCTGCTCCTT*       257997--258071
  Nonsense mutagenesis of essential genes^c^                                                                                                                                                        
      ORF32                                                ORF32.T237G-sense         GACAACGGCTGGGGCTA[*G*]{.ul}ACCTTTCTGATCCAATC                                                                   54711--54745
                                                           ORF32.A237C-antisense     GATTGGATCAGAAAGGT[*C*]{.ul}TAGCCCCAGCCGTTGTC                                                                   54745--54711
      ORF59                                                ORF59.C144G-sense         CATGCAGCGCTA[*G*]{.ul}CAACTGTGCGAG                                                                             102315--102291
                                                           ORF59.G144C-antisense     CTCGCACAGTTG[*C*]{.ul}TAGCGCTGCATG                                                                             102291--102315
      ORF81                                                ORF81.C207G-sense         TTGCGCACGCCATGTA[*G*]{.ul}TCCAACGATCCC                                                                         150987--151015
                                                           ORF81.G207C-antisense     GGGATCGTTGGA[*C*]{.ul}TACATGGCGTGCGCAA                                                                         151015--150987
      ORF83                                                ORF83.G225A-sense         GTTCATGTACTG[*A*]{.ul}GTCACCCTACGC                                                                             153268--153244
                                                           ORF83.C225T-antisense     GCGTAGGGTGAC[*T*]{.ul}CAGTACATGAAC                                                                             153244--153268
      ORF99                                                ORF99.C3039G-sense        CAACGACAGGTTCTCGTA[*G*]{.ul}GTGGCGAGCC                                                                         184946--184974
                                                           ORF99.G3039C-antisense    GGCTCGCCAC[*C*]{.ul}TACGAGAACCTGTCGTTG                                                                         184974--184946
      ORF106                                               ORF106.CA108AT-sense      CTTCGTCGTCTA[*AT*]{.ul}AGGCCCAGCAC                                                                             195872--195896
                                                           ORF106GT108TA-antisense   GTGCTGGGCCT[*AT*]{.ul}TAGACGACGAAG                                                                             195896--195872
      ORF115                                               ORF115.C744A-sense        GGACCTGGTCCTGTA[*A*]{.ul}TCCCAGACGAACGTG                                                                       208955--208985
                                                           ORF115.G744T-antisense    CACGTTCGTCTGGGA[*T*]{.ul}TACAGGACCAGGTCC                                                                       208985--208955
      ORF131                                               ORF131.C735G-sense        TCCAGGGCCGTGTA[*G*]{.ul}GAGGCCGC                                                                               226054--226032
                                                           SDM131.G735C-antisense    GCGGCCTC[*C*]{.ul}TACACGGCCCTGGA                                                                               226032--226054
  Synthesis of probes for Southern analysis (probe name)                                                                                                                                            
      *GalK*                                               *GalK*.Int2-F             AGGTGAGGAACTAAACCCAG                                                                                           
                                                           *GalK*.Int2-R             CGTATTGCAGCAGCTTTATC                                                                                           
      ORF32                                                ORF32.SB-F                CAGATGTGGCTGGACATGA                                                                                            54567--54585
                                                           ORF32.SB-R                GCTACCCAGGTGGTGTTGTT                                                                                           55006--54987
      ORF59                                                ORF59.SB-F                GTTCTGCGTCGAGGATGATG                                                                                           102042--102061
                                                           ORF59.SB-R                CGTTCAGCACCTCGGTCTAC                                                                                           102427--102408
      ORF81                                                ORF81.SB-F                AAAGCTCAACTGGCCAAGAG                                                                                           150809--150828
                                                           ORF81.SB-R                ACACCGCCGTCTTCGAGTAG                                                                                           151259--151240
      ORF83                                                ORF83.SB-F                TGCTCTCCACGTCCTTGTA                                                                                            152838--152856
                                                           ORF83.SB-R                ATGTCTCCTTTGTGCGGTC                                                                                            153480--153462
      ORF99                                                ORF99.SB-F                CCTCCAGACGCAGATCAACT                                                                                           184751--184770
                                                           ORF99.SB-R                CTTGAGGAAGGGCTGGTTG                                                                                            185204--185186
      ORF106                                               ORF106.SB-F               GCAGCAGCAGCAGAAGTG                                                                                             195783--195800
                                                           ORF106.SB-R               TCAGTTGGTCTTGGGGCC                                                                                             196013--195996
      ORF115                                               ORF115.SB-F               CTACGCCAACGACGAACC                                                                                             209426--209443
                                                           ORF115.SB-R               AGCACCACGAACCACACTC                                                                                            209776--209758
      ORF131                                               ORF131.SB-F               ACTGGAGCGGGTGATAGTTG                                                                                           225487--225506
                                                           ORF131.SB-R               GGACTCGTCGTGCCTCTC                                                                                             225937--225920
  PCR                                                                                                                                                                                               
      ORF25                                                ORF25int_F                ATCAAGCGCTACGACGACTT                                                                                           45948--45967
                                                           ORF25int_R                TGTTGCAGGAGGTGTAGACG                                                                                           46442--46461
      ORF64                                                ORF64int_F                CCATAGTCCAGGACGACGAT                                                                                           121431--121450
                                                           ORF64int_R                TGCTGCTTGATGTTCTCCAC                                                                                           121919--121938
      ORF65                                                ORF65int_F                GATGGTCATGTTGGTGTTGC                                                                                           122996--123015
                                                           ORF65int_R                CCAAGAACGAGCTCTTCACC                                                                                           123494--123513
      ORF108                                               ORF108int_F               ACCAACTACACGACCGTCTC                                                                                           201246--201265
                                                           ORF108int_R               CCGGGTTGGTGTAGGTAGAA                                                                                           201677--201696
      ORF132                                               ORF132int_F               TTGGTTTTTGTTGGTGACGA                                                                                           227468--227487
                                                           ORF132int_R               TGACGGGTTCCAAGATTAGC                                                                                           227936--227955
      ORF136                                               ORF136int_F               CTGGTTACATGGGTGGCTTT                                                                                           231360--231379
                                                           ORF136int_R               TAGCCCCTGTTGTAGGATGC                                                                                           231738--231757
      ORF148                                               Pr148fw2                  GGTTGTTGGAGTAGTGGTGC                                                                                           254196--254215
                                                           Pr148rev2                 CTCATTCAGGCTCGGAGAC                                                                                            254592--254610
      ORF149                                               Pr149fw1                  GTAGTCGCTGGATGTGACG                                                                                            256662--256680
                                                           Pr149rev1                 GTCAACACGGACTGCTCCG                                                                                            257093--257111
      ORF112                                               ORF112intFW               CCAGTGTCATCACCACAAGC                                                                                           205336--205355
                                                           ORF112intREV              ACGGACATCCTGGGTATCAA                                                                                           205571--205590
  qPCR                                                                                                                                                                                              
      CyHV-3 ORF89                                         KHV-86F                   GACGCCGGAGACCTTGTG                                                                                             [AF411803](https://www.ncbi.nlm.nih.gov/nuccore/AF411803)
                                                           KHV-163R                  CGGGTTCTTATTTTTGTCCTTGTT                                                                                       
                                                           KHV-109P                  (6FAM) CTTCCTCTGCTCGGCGAGCACG (BHQ1)                                                                           
      Carp glucokinase                                     CgGluc-162F               ACTGCGAGTGGAGACACATGAT                                                                                         [AF053332](https://www.ncbi.nlm.nih.gov/nuccore/AF053332)
                                                           CgGluc-230R               TCAGGTGTGGAGCGGACAT                                                                                            
                                                           CgGluc-185P               (6FAM) AAGCCAGTGTCAAAATGCTGCCCACT (BHQ1)                                                                       

Coordinates are listed in relation to GenBank accession number [NC_009127.1](https://www.ncbi.nlm.nih.gov/nuccore/NC_009127.1).

Underlined: segments correspond to the CyHV-3 sequence; italicization indicates sequences corresponding to *galK* sequence. Mutated nucleotides are both underlined and italicized.

Production of CyHV-3 FL BAC recombinant plasmids and CyHV-3 recombinant viruses using BAC cloning and prokaryotic recombination technologies. {#sec3-6}
---------------------------------------------------------------------------------------------------------------------------------------------

CyHV-3 FL BAC recombinant plasmids and CyHV-3 recombinant viruses were produced on the basis of the strategy outlined in [Fig. 2](#F2){ref-type="fig"} and [8](#F8){ref-type="fig"}, by using a two-step galactokinase gene (*galK*) positive/negative selection in bacteria ([@B15], [@B23]). Single-gene deleted recombinant plasmids were produced for various ORFs by replacing the sequence (initiation codon to stop codon) by a *galK* expression cassette (*galK* positive selection). Recombination cassettes encoding *galK* were produced by PCR using the primers listed in [Table 3](#T3){ref-type="table"} and the p*galK* vector as the template. The derived ORFX Del *galK* cassette consisted of the *galK* gene flanked by 75-bp sequences homologous to the regions of the CyHV-3 genome immediately upstream and downstream of ORFX. The flanking sequences served as targets to induce homologous recombination with the FL BAC parental plasmid in competent E. coli cells, resulting in replacement of the entire ORF by the *galK* expression cassette (FL BAC ORFX Del *galK* plasmid).

The recombinant FL BAC plasmids were transfected into permissive CCB cells in the presence of polyethylenimine (PEI). Transfection of the BAC plasmids and eventual reconstitution of infectious virus were monitored by epifluorescence microscopy, since the FL BAC plasmids and derived viruses contained an EGFP expression cassette. For mutations that did not prevent reconstitution of infectious virus (i.e., in nonessential genes), cell supernatants were collected and the viruses were amplified, leading to FL BAC recovered ORFX Del *galK* viruses. For mutations that prevented reconstitution of infectious virus (i.e., in essential genes), further investigations were performed. For each ORF identified as being essential for viral growth, WT revertant (Rev1) and nonsense (NS) mutation clones were produced by using a second recombination process (*galK* negative selection). ORFX Rev1 and ORFX NS recombination cassettes were produced by PCR using WT FL BAC DNA and pGEMT-ORFX NS as the templates, respectively (see [Table 3](#T3){ref-type="table"} for primers). The resulting FL BAC ORFX Rev1 and FL BAC ORF X NS plasmids were transfected into CCB cells as described above. To exclude the possibility that the lack of infectivity of the NS-null recombinant BAC plasmids was due to unexpected mutations during BAC manipulation, FL BAC ORFX NS plasmids were also transfected into CCB cells together with a WT DNA fragment containing the appropriate ORF and upstream and downstream flanking regions, in order to induce reversion to a WT sequence after homologous recombination in eukaryotic cells.

Genetic characterization of CyHV-3 recombinant BAC plasmids and derived recombinant viruses. {#sec3-7}
--------------------------------------------------------------------------------------------

CyHV-3 FL BAC recombinant plasmids and derived recombinant viruses were characterized by sequencing regions of interest and by assessing the sizes of SacI fragments by agarose gel electrophoresis and Southern blotting ([@B24]). Probes for Southern blotting were produced by PCR using the primers listed in [Table 3](#T3){ref-type="table"}. CyHV-3 recombinant viruses deleted for nonessential genes (the FL BAC recovered ORFX Del *galK* viruses and the FL BAC revertant ORF25 Del *galK* virus) were characterized further by full-length genome sequencing as described previously ([@B15]).

Indirect immunofluorescence staining. {#sec3-8}
-------------------------------------

Cells grown on glass coverslips were fixed in phosphate-buffered saline (PBS) containing 4% (wt/vol) paraformaldehyde at 4°C for 15 min and then 20°C for 10 min. After a washing step with PBS, samples were permeabilized in PBS containing 0.1% (vol/vol) NP-40 at 37°C for 15 min ([@B15]). Immunofluorescence staining (incubation and washes) was performed in PBS containing 10% (vol/vol) fetal calf serum (FCS). Monospecific mouse pAbs (dilution 1:100) against CyHV-3 ORF148 or ORF149 were used as the primary antibody, followed by Alexa Fluor 568 goat anti-mouse immunoglobulin G(H+L) (Invitrogen) as the secondary antibody (1:1,000 dilution). After a washing step, the cells were mounted by using Prolong Gold antifade reagent with DAPI (4′,6′-diamidino-2-phenylindole; Invitrogen). Samples were analyzed by confocal microscopy using a Leica SP5 confocal microscope ([@B14]).

Multistep growth curves. {#sec3-9}
------------------------

Triplicate cultures of CCB cells were infected with CyHV-3 viruses at an MOI of 0.05 PFU/cell. After incubation for 2 h, the cells were washed with PBS and overlaid with Dulbecco modified Eagle medium (DMEM) containing 4.5 g/liter glucose and 10% (vol/vol) FCS. The supernatant was removed from the infected cultures at successive intervals (2, 4, and 6 dpi) and stored at −80°C. Titers of infectious viral particles were determined by duplicate plaque assays in CCB cells ([@B24]).

Plaque size assay. {#sec3-10}
------------------

CCB cells grown in 6-well plates were infected with viruses at an MOI of 200 PFU/well. After incubation for 2 h, the cells were overlaid with DMEM containing 10% (vol/vol) FCS and 0.6% (wt/vol) carboxymethyl cellulose (medium viscosity; Sigma) in order to obtain isolated plaques ([@B25]). At successive intervals after infection, the plaques were fixed in PBS containing 4% (wt/vol) paraformaldehyde at 4°C for 15 min and then 20°C for 10 min. Images were captured with a confocal microscope (Nikon A1R). For each virus, 25 plaques were measured in duplicate wells. The plaque area was measured by using ImageJ 1.46 software ([@B26]).

Fish. {#sec3-11}
-----

Common carp (Cyprinus carpio) were kept in 60-liter tanks at 24°C. Water parameters were checked twice per week. The health of the fish was confirmed by microbiological, parasitic, and clinical examination immediately prior to the experiments, all of which were preceded by an acclimation period of at least 2 weeks.

Inoculation of fish with CyHV-3. {#sec3-12}
--------------------------------

Two modes of inoculation were used: immersion in infectious water and cohabitation with newly infected fish. For inoculation by immersion, the fish were immersed for 2 h in constantly aerated water containing virus, the volume of water being adjusted to a biomass of around 10% on the basis of fish size and number. At the end of the incubation period, the fish were returned to 60-liter tanks. For inoculation by cohabitation, naive fish were immersed for 2 h in water containing 400 PFU/ml of the FL or M3 strain of CyHV-3. The newly infected fish were then released into tanks at a ratio of 2 newly infected fish per 20 fish to be infected.

Ethics statement. {#sec3-13}
-----------------

The maintenance and care of fish and the experiments conducted complied with the guidelines of the *European Convention for the Protection of Vertebrate Animals Used for Experimental and other Scientific Purposes* (CETS 123). The animal studies were approved by the local ethics committee of the University of Liège, Belgium (laboratory accreditation 1610008, protocol 1414). All efforts were made to minimize suffering.

Quantification of virus genome copies in organs by real-time TaqMan PCR. {#sec3-14}
------------------------------------------------------------------------

The virus genome was quantified by real-time TaqMan PCR as described previously ([@B24]), by amplifying fragments of the CyHV-3 ORF89 and carp glucokinase genes. The primers and probes are listed in [Table 3](#T3){ref-type="table"}.

Statistical analysis. {#sec3-15}
---------------------

Viral growth ([Fig. 5A](#F5){ref-type="fig"}) and plaque size ([Fig. 5B](#F5){ref-type="fig"}) results were compared by using two-way analysis of variance (ANOVA) with interactions, followed by a post hoc Student *t* test. qPCR results ([Fig. 9](#F9){ref-type="fig"}) were compared using one-way ANOVA, followed by a post hoc Student *t* test. Survival curves ([Fig. 6](#F6){ref-type="fig"} and [10](#F10){ref-type="fig"}) were compared by using log-rank tests. These analyses were done by using GraphPad Prism 5. The variables used and comparisons retained for statistical illustrations are presented in the figure legends. Statistical significance is represented in the figures by asterisks as follows: \*, *P* \< 0.05; \*\*, *P* \< 0.01; and \*\*\*, *P* \< 0.001.
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